Version 5.4
Bos taurus Protein: EBF1
Summary
InnateDB Protein IDBP-699220.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol EBF1
Protein Name early B-cell factor 1
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000053340
InnateDB Gene IDBG-646416 (EBF1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 7 interaction(s) predicted by orthology.
Predicted by orthology
Total 7 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0005515 protein binding
GO:0046872 metal ion binding
GO:0046983 protein dimerization activity
Biological Process
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0007275 multicellular organismal development
GO:0045893 positive regulation of transcription, DNA-templated
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR002909 IPT domain
IPR011598 Myc-type, basic helix-loop-helix (bHLH) domain
IPR014756 Immunoglobulin E-set
PFAM PF01833
PF00010
PRINTS
PIRSF
SMART SM00429
SM00353
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BPV4
UniProt Splice Variant
Entrez Gene 537712
UniGene Bt.110752
RefSeq NP_001179845
HUGO HGNC:3126
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02020841 DAAA02020842 DAAA02020843 DAAA02020844
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca